23andMe, Genentech sign USD 60 million deal on Parkinson’s treatment

January 7, 2015 11:59 PM

13 0

Private firm 23andMe Inc and Genentech on Tuesday announced that they have signed a USD 60 million agreement under which they will jointly work on generating whole genome sequencing data for the people with Parkinson’s disease.

Both the companies will involve nearly 3,000 patients of Parkinson’s disease and get their genome sequencing so that their data could be compiled together for future research works.

Read more

To category page